http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2135203-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_214eefdc25fd7745d0d36aa459a9cbaa |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-00 |
filingDate | 1999-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1999-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aafa93f1de022cc14eaeb790294f61b5 |
publicationDate | 1999-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2135203-C1 |
titleOfInvention | Agent showing adaptogenic effect |
abstract | FIELD: medicine, food industry. SUBSTANCE: proposed agent has laminaria concentrate, sucrose and lactose at the following ratio of components, g: laminaria concentrate 0.3-0.10; sucrose 0.04-0.10, and lactose 0.10-0.30. An agent shows adaptogenic effect and can be used for increase of physical efficiency, prophylaxis and treatment of immunodeficiency states induced by chronic and relapse infections, radiation and other environment factors. EFFECT: enhanced natural resistance of body to unfavorable factors of environment, normalization of lipid metabolism, radioprotective effect. 1 cl, 4 tbl, 3 ex |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2487717-C1 |
priorityDate | 1999-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 56.